News

GrubMarket raises $60M as food delivery stays center stage

​

Veem Secures $31M in Strategic Funding Round

​

Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline

​

Monte Rosa Therapeutics Announces $96 Million Series B Financing to Advance Protein Degradation Platform

​

Antios Therapeutics Announces Publication Describing Preclinical Profile

​

Northern Biologics reports the Phase 1 Dose Escalation of MSC-1, a humanized anti-LIF monoclonal antibody

​

Libra Launches with $29M Series A to Develop Novel Therapeutics for Neurodegenerative Diseases

​

UCB acquires Engage Therapeutics

​

Schrödinger Announces Expanded Collaboration with AstraZeneca

​